Immediate Impact
52 standout
Citing Papers
Epigenetics-targeted drugs: current paradigms and future challenges
2024 Standout
Targeted therapy for head and neck cancer: signaling pathways and clinical studies
2023 Standout
Works of Felix Keil being referenced
Docetaxel, cisplatin and 5-FU compared with docetaxel, cisplatin and cetuximab as induction chemotherapy in advanced squamous cell carcinoma of the head and neck: Results of a randomised phase II AGMT trial
2021
Induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil followed by radiotherapy with cetuximab for locally advanced squamous cell carcinoma of the head and neck
2012
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Felix Keil | 660 | 198 | 112 | 287 | 225 | 79 | 1.1k | |
| Kimikazu Yakushijin | 545 | 206 | 151 | 266 | 190 | 131 | 1.1k | |
| Thomas Kiss | 741 | 130 | 131 | 364 | 255 | 73 | 1.2k | |
| Riccardo Ghio | 622 | 224 | 160 | 273 | 255 | 93 | 1.2k | |
| C. Annaloro | 588 | 171 | 106 | 247 | 224 | 55 | 1.3k | |
| Jiří Vorlíček | 474 | 231 | 71 | 264 | 145 | 81 | 955 | |
| David Michonneau | 413 | 269 | 127 | 253 | 403 | 78 | 1.1k | |
| Hirokazu Okumura | 432 | 179 | 219 | 369 | 207 | 77 | 1.1k | |
| Tomoaki Fujisaki | 426 | 204 | 163 | 340 | 215 | 61 | 891 | |
| Shinjiro Todo | 709 | 254 | 90 | 235 | 438 | 78 | 1.3k | |
| Fumihiko Ishimaru | 347 | 245 | 102 | 306 | 322 | 92 | 1.0k |
All Works
Login with ORCID to disown or claim papers
Loading papers...